QCDR measure AAD 20
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience
DESCRIPTION:
Percentage of adult patients (age 18 years and older) who report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis. Patients provide a global assessment of the perceived effectiveness of the AK treatment approach or management plan. Improvements in patient perceptions of AK treatment approaches and management plans will enhance patient-provider communication and foster more patient-centered approaches to care.
| MEASURE ID: | AAD20 |
|---|---|
| Type: | Patient Reported Outcome-Based Performance Measure (PRO-PM) |
CMS Derm Specialty Set: | N/A |
| High priority: | Yes |
| Topped out: | No |
| Telehealth Eligible: | No |
| Reporting methods: | Registry/QCDR |
| Maximum points: | 10 |
MEASURE PURPOSE:
Patient perceptions of treatment and/or management approaches may significantly affect treatment choice and adherence that facilitate patient-centered approaches to care. Evaluating patient’s perceptions of treatment effectiveness may help healthcare providers more effectively tailor care based on the patient’s medical needs and personal preferences.
AAD20 FAQs
Q. Is this measure reportable via claims?
A. No. This measure can only be reported via a registry, such as DataDerm.
Q. Are patient encounters conducted via telehealth allowable?
A. No. Telehealth encounters are not allowable.
Q. What is the numerator?
A. The numerator is adult patients (>18 years old) who self-reported favorable outcomes resulting from the treatment or management approaches used for Actinic Keratosis (AK), as assessed by two Likert-type scales. The mean responses of both questions must be >4, indicating positive perceptions of treatment outcomes or management plans.
Q. What is the denominator?
A. The denominator includes all adult patients (>18 years of age) who have an encounter during the performance period and a diagnosis of Actinic Keratosis (L57.0). Eligible CPT codes for encounters include 99211-99215, 17000, 17003, 17004, 96567, 96573, and 96574. The encounter must also be within 12 months prior to the performance period.
Q. Are there any exclusions for this measure?
A. Yes. Patients with severe mental and/or physical incapacity that prevents them from answering the self-report questions are excluded.
Q. Are there any exceptions for this measure?
A. No, there are no exceptions.
Q. Is this an inverse measure?
A. No. This is not an inverse measure.
Q. How is the numerator data collected?
A. The data is collected through two five-item Likert-type scales:
“How would you rate your AKs now compared to before treatment?” (Scale: 1-5)
“How would you rate your ability to follow the management plan?” (Scale: 1-5) Both questions must have a response to meet data completeness.
Q. Can this measure be reported by a dermatologist who treats Actinic Keratosis?
A. Yes, any dermatologist who treats AK and engages in management or treatment plans can report this measure, if the required patient demographics and performance criteria are met.
Q. What are the treatment outcomes being assessed?
A. The treatment outcomes are patients’ self-reported perceptions regarding the effectiveness of their AK treatment or management plan, which may include active treatment or surveillance without treatment.
Calculation
The numerator: Adult patients (age 18 years and older) who self-reported perceived outcomes resulting from the treatment or management approaches used to address their diagnosed AK using two five-item Likert-type scales that range from 1 to 5. Mean responses of the two questions of 4 or greater is interpreted as positive patient perceptions of treatment outcomes or the management approach that facilitates patient-centered care. Both questions must have a response to meet data completeness for this measure.
The denominator: All adult patients, age 18 years and older.
Important note
For new measures in their first year in the program, if the clinician meets data completeness, they earn at least 7 points.
Find a Dermatologist
Member directory
AAD Learning Center
2026 AAD Annual Meeting
Need coding help?
Reduce burdens
Clinical guidelines
Why use AAD measures?
New insights
Physician wellness
Joining or selling a practice?
Promote the specialty
Advocacy priorities